Skip to content

FASSKA - PAR: what changed

BE 0444.198.434NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€8.8m
2024 · €11.7m-€2.9m
Equity
€29.3m
2024 · €20.4m+€8.8m
Cash
€1.7m
2024 · €7.0m-€5.3m
Balance sheet total
€37.3m
2024 · €32.8m+€4.5m

Largest movements

2024 to 2025
Assets
  • Current investments +€9.8m

    up €9.8m (+110%), from €8.9m to €18.7m

  • Cash -€5.3m

    down €5.3m (-75.3%), from €7.0m to €1.7m

    mainly Current investments (-€9.8m) and Advances received (-€4.3m)

Equity and liabilities
  • Profit (loss) carried forward +€7.8m

    up €7.8m (+56.8%), from €13.8m to €21.6m

  • Advances received -€4.3m

    down €4.3m (-82.1%), from €5.2m to €939,138

  • Reserves +€997,770

    up €997,770 (+15.4%), from €6.5m to €7.5m

    of which Tax-exempt reserves: +€997,770

Income statement
  • Turnover -€14.3m

    down €14.3m (-16.1%), from €88.5m to €74.3m

  • Goods and materials -€10.1m

    down €10.1m (-15.3%), from €66.0m to €55.9m

  • Services and other goods -€1.1m

    down €1.1m (-15.9%), from €6.8m to €5.8m

  • Taxes -€992,656

    down €992,656 (-25.2%), from €3.9m to €3.0m

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €11.7m
Turnover -€14.3m
Other operating income -€91,828
Goods and materials +€10.1m
Services and other goods +€1.1m
Staff costs +€144,509
Depreciation +€4,264
Write-downs +€414
Other operating items +€2,845
Financial income -€838,951
Financial charges -€28,616
Taxes +€992,656
Result 2025 €8.8m
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€4.5m
Investment -€9.8m
Financing €0
Cash 2024 €7.0m
Net result for the year +€8.8m
Depreciation +€56,275
Receivables within one year +€230,263
Deferred charges and accrued income -€277,341
Trade debts +€111,088
Tax, wage and social debts -€98,673
Advances received -€4.3m
Investment in fixed assets (net) -€9,267
Current investments -€9.8m
Cash 2025 €1.7m
brings cash intakes cash out
Every line side by side 60 lines
Line Code 2024 2025 Change %
Total assets 20/58 €32,778,731 €37,302,855 +€4.5m +13.8%
Fixed assets 21/28 €182,708 €135,701 -€47,007 -25.7%
Tangible fixed assets 22/27 €182,708 €135,701 -€47,007 -25.7%
Land and buildings 22 €4,293 €296 -€3,998 -93.1%
Plant, machinery and equipment 23 €8,835 €6,936 -€1,899 -21.5%
Furniture and vehicles 24 €169,579 €128,469 -€41,111 -24.2%
Current assets 29/58 €32,596,023 €37,167,155 +€4.6m +14.0%
Amounts receivable within one year 40/41 €16,632,736 €16,402,473 -€230,263 -1.4%
Trade receivables 40 €13,560,295 €16,210,218 +€2.6m +19.5%
Other amounts receivable 41 €3,072,441 €192,255 -€2.9m -93.7%
Current investments 50/53 €8,900,000 €18,685,135 +€9.8m +110%
Other investments 51/53 €8,900,000 €18,685,135 +€9.8m +110%
Cash at bank and in hand 54/58 €6,988,814 €1,727,733 -€5.3m -75.3%
Deferred charges and accrued income 490/1 €74,472 €351,813 +€277,341 +372%
Total equity and liabilities 10/49 €32,778,731 €37,302,855 +€4.5m +13.8%
Equity 10/15 €20,436,196 €29,254,478 +€8.8m +43.2%
Contributions 10/11 €200,000 €200,000 = 0.0%
Capital 10 €200,000 €200,000 = 0.0%
Issued capital 100 €200,000 €200,000 = 0.0%
Reserves 13 €6,469,315 €7,467,085 +€997,770 +15.4%
Non-distributable reserves 130/1 €20,000 €20,000 = 0.0%
Legal reserve 130 €20,000 €20,000 = 0.0%
Tax-exempt reserves 132 €1,969,715 €2,967,485 +€997,770 +50.7%
Distributable reserves 133 €4,479,600 €4,479,600 = 0.0%
Profit (loss) carried forward 14 €13,766,881 €21,587,394 +€7.8m +56.8%
Amounts payable 17/49 €12,342,535 €8,048,377 -€4.3m -34.8%
Amounts payable within one year 42/48 €12,342,535 €8,048,377 -€4.3m -34.8%
Trade debts 44 €3,039,659 €3,150,747 +€111,088 +3.7%
Suppliers 440/4 €3,039,659 €3,150,747 +€111,088 +3.7%
Advances received on contracts in progress 46 €5,245,712 €939,138 -€4.3m -82.1%
Taxes, remuneration and social security 45 €458,656 €359,983 -€98,673 -21.5%
Taxes 450/3 €273,927 €198,089 -€75,839 -27.7%
Remuneration and social security 454/9 €184,728 €161,894 -€22,834 -12.4%
Other amounts payable 47/48 €3,598,509 €3,598,509 = 0.0%
Operating income 70/76A €89,126,548 €74,770,491 -€14.4m -16.1%
Turnover 70 €88,541,245 €74,274,171 -€14.3m -16.1%
Other operating income 74 €568,991 €477,163 -€91,828 -16.1%
Non-recurring operating income 76A €16,311 €19,157 +€2,845 +17.4%
Operating charges 60/66A €74,609,495 €63,288,808 -€11.3m -15.2%
Goods for resale, raw materials and consumables 60 €66,022,312 €55,940,903 -€10.1m -15.3%
Purchases 600/8 €66,022,312 €55,940,903 -€10.1m -15.3%
Services and other goods 61 €6,843,863 €5,753,771 -€1.1m -15.9%
Remuneration, social security and pensions 62 €1,682,368 €1,537,859 -€144,509 -8.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €60,539 €56,275 -€4,264 -7.0%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €414 - -€414
Operating profit (loss) 9901 €14,517,052 €11,481,683 -€3.0m -20.9%
Financial income 75/76B €1,230,192 €391,242 -€838,951 -68.2%
Recurring financial income 75 €1,230,192 €391,242 -€838,951 -68.2%
Income from current assets 751 €1,148,320 €390,607 -€757,713 -66.0%
Other financial income 752/9 €81,873 €635 -€81,238 -99.2%
Financial charges 65/66B €75,574 €104,190 +€28,616 +37.9%
Recurring financial charges 65 €75,574 €104,190 +€28,616 +37.9%
Other financial charges 652/9 €75,574 €104,190 +€28,616 +37.9%
Profit (loss) for the period before taxes 9903 €15,671,671 €11,768,735 -€3.9m -24.9%
Income taxes 67/77 €3,943,108 €2,950,452 -€992,656 -25.2%
Taxes 670/3 €3,943,108 €2,950,452 -€992,656 -25.2%
Profit (loss) for the period 9904 €11,728,562 €8,818,283 -€2.9m -24.8%
Transfer from tax-exempt reserves 789 €30,035 - -€30,035
Transfer to tax-exempt reserves 689 - €997,770 +€997,770
Profit (loss) for the period to be appropriated 9905 €11,758,598 €7,820,513 -€3.9m -33.5%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€51.7m to €66.6m

Midpoint €57.9m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €29.3m
Capitalised earnings €74.2m to €103.9m
Indication €51.7m to €66.6m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€29,254,478
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€29.3m

Capitalised earnings

net result for the year (9904)
2025
€8,818,283
excluding non-recurring income and charges
€8,799,126
2024
€11,728,562
excluding non-recurring income and charges
€11,712,251
2023
€10,681,287
excluding non-recurring income and charges
€10,666,487
2022
€5,880,690
excluding non-recurring income and charges
€5,870,376
2021
€5,441,475
excluding non-recurring income and charges
€5,439,575
Average result, excluding non-recurring income and charges
€10,392,621
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€74.2m / €86.6m / €103.9m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.